Clinical Trials Logo

Cold Urticaria clinical trials

View clinical trials related to Cold Urticaria.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04513548 Terminated - Clinical trials for Chronic Spontaneous Urticaria

Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria

MASTER
Start date: August 5, 2020
Phase: Phase 1
Study type: Interventional

The purpose of the study is to investigate the mechanism of action for ligelizumab (QGE031) treatment in patients with chronic urticaria. The study has two parts. The study population will consist of approximately 68 male and female healthy volunteers and patients. In Part 1, approximately 20 healthy volunteers and patients with chornic urticaria will be enrolled. In Part 2 approximately 48 patients with chronic urticaria (spontaneous chronic urticaria, cholinergic urticaria or cold urticaria). Part 1 consists of a screening period up 2 weeks and a visit with skin tests; there is no treatment taken in Part 1. Part 2 is randomized, subject, investigator and sponsor blinded. It consists of a screening period up to 4 weeks, a 16 week treatment period and a 12-week follow-up period after last treatment. A follow-up call at Week 32 will be performed via telephone.